Vasopressor combination

This page covers all Vasopressor combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Alpha-1 adrenergic receptor, beta-1 adrenergic receptor, vasopressin V1 receptor, Alpha-1 adrenergic receptor, beta-1 adrenergic receptor, V1 vasopressin receptor.

Targets

Alpha-1 adrenergic receptor, beta-1 adrenergic receptor, vasopressin V1 receptor · Alpha-1 adrenergic receptor, beta-1 adrenergic receptor, V1 vasopressin receptor

Marketed (1)

• norepinephrine+vasopressin · Peking Union Medical College Hospital · Critical Care / Cardiovascular
  This combination of norepinephrine and vasopressin acts as a dual vasopressor agent that increases blood pressure and tissue perfusion through alpha-adrenergic stimulation and vasopressin V1 receptor activation.

Phase 3 pipeline (1)

• Norepinephrine and Vasopressin for Rescue · Hospital do Coracao · Critical Care / Cardiovascular
  This combination therapy uses norepinephrine and vasopressin to increase blood pressure and peripheral vascular resistance in patients with refractory hypotension or shock.